Navigation Links
BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility

INDIANAPOLIS, May 26, 2011 /PRNewswire/ -- BioStorage Technologies, the premier global provider of comprehensive sample management solutions, announced today that it has opened its new state-of-the-art biorepository facility in Indianapolis. The 60,000-square-foot facility is part of the company's strategic growth plan, and represents a 4.6MM investment by BioStorage Technologies.

Strategically placed near the second largest FedEx hub in the United States, the new facility is dedicated to the preparation, storage and cold-chain transport of human biological samples for a wide variety of customers, including academic centers, contract research organizations, donor programs and biotechnology companies. BioStorage Technologies is continuing to employ a growing number of sample management experts, making it one of the largest and most technology-driven biorepositories in the world.  

"BioStorage Technologies is committed to its investment in comprehensive sample management solutions, and this new facility provides the company with the infrastructure needed to support our continued growth and expanded services," said Greg Swanberg, CEO of BioStorage Technologies.

The facility expansion has provided BioStorage Technologies the ability to offer sample preparation services, including automated liquid handling technology to ensure the accuracy and precision needed for high-throughput DNA and RNA extraction and verification.

The integration of these services allows BioStorage Technologies to provide customers with a sample renewal and extension process to maximize their samples for comprehensive research and development activities. Once samples are processed, aliquots of blood and/or DNA products can be retrieved and scheduled for transport to research testing sites through the company's proprietary tracking and inventory management system, ISISS®. This process ensures samples are removed, transported, processed and replaced to storage in a compliant, consistent and efficient fashion.

"The future of drug discovery is in personalized medicine and genomic-based therapies, which will require an ability to store and analyze large quantities of tissue and blood samples," added Swanberg. "As this trend continues, an increasing amount of pharma and biotech companies rely on our expertise in comprehensive sample management to ensure their valuable biological samples are managed in optimal conditions and not jeopardized by pre-analytical variables that can have a negative impact on sample integrity."  

The new biorepository facility offers a wide range of storage options, including automated carousel controlled-room temperature storage at 15 degrees C to 27 degrees C, bulk sample storage at 15 degrees C to 27 degrees C, walk-in cold sample storage -20 degrees C to 5 degrees C, ultra-low temperature storage -70 degrees C to -80 degrees C, and -190 degrees C vapor phase liquid nitrogen. In addition, BioStorage Technologies maintains FDA 21 CFR Part 11 validated technology systems and adheres to U.S. Food and Drug Administration regulations, as well as U.S. Department of Transportation and International Air Transport Association guidelines.

About BioStorage Technologies, Inc.:

BioStorage Technologies Inc. is the premier global provider of comprehensive sample management and onsite solutions for the bioscience industry. Offering a team of sample management experts, state-of-the-art temperature-controlled storage facilities, a real-time, web-based sample intelligence and tracking, BioStorage Technologies manages the complete life-cycle of sample assets enabling companies to maximize opportunities, minimize risk and reduce costs. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.

SOURCE BioStorage Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Appoints New Director of Business Development for European Operations
2. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
3. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
4. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISSĀ®
5. BioStorage Technologies Appoints New Vice President of Global Sales
6. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
7. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
8. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
9. BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
10. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
11. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... ALBANY, New York , November 24, 2015 /PRNewswire/ ... According to a recent market research report released by ... is projected to expand at a CAGR of 17.5% ... titled "Non-invasive Prenatal Testing Market - Global Industry Analysis, ... 2022", estimates the global non-invasive prenatal testing market to ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
Breaking Biology News(10 mins):